During the pandemic, Rodrigue started following social media creators posting about losing weight after using drugs like ...
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...
Today it is happening again with GLP1 agonists like Semaglutide with the brand names of Wegovy, Ozempic, and Rybelsus and similar drugs like Moujaro and Zepbound. And just like all the other weight ...
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...
Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.
As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...
The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...